Advanced Squamous Cell Carcinomas of the Pelvic and Perineal Region: A Comprehensive Genomic Profiling Study.
Andrea NecchiPhilippe E SpiessMarco BandiniGiuseppe BasilePetros GrivasGennady BratslavskyJoseph JacobNatalie DanzigerDouglas LinBrennan DeckerEthan S SokolRichard S P HuangSanjay B KulkarniJeffrey S RossPublished in: The oncologist (2022)
Despite similar histology, pSCCs can differ in GAs and HPV status. Overall, PIK3CA is the most frequent potentially "targetable" GA followed by mTOR and cell cycle pathway. RTK and DDR GAs are rare in pSCC. Immunotherapy could be considered for pSCC management based on TMB and PD-L1 expression.